Drug Testing Locations - Palos Park, IL

Drug Testing in Palos Park, IL

Palos Park, Illinois Statistics

In Palos Park, IL, located in Cook County, opioid-related deaths accounted for 60% of drug fatalities in 2021.

Cook County data shows a 15% increase in drug overdoses in Palos Park, IL in 2022.

In 2021, Palos Park, in Cook County, saw a 25% rise in admissions to drug rehab facilities.

The number of drug-related arrests in Palos Park, Cook County, rose by 10% in 2022.

Palos Park, IL experienced a surge in synthetic drug use, with a 20% increase in related cases in Cook County.

Drug-related emergency room visits in Palos Park, Cook County, rose by 12% in 2020.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Palos Park, IL & Drug Testing Policies

Employers in Palos Park, IL, recognize the impact of drug use on workplace safety and productivity. Many implement drug-testing policies to ensure a safe environment. Cook County businesses adhere to guidelines from the Occupational Safety and Health Administration.

Local companies often collaborate with organizations like Substance Abuse and Mental Health Services Administration (SAMHSA) to create comprehensive drug-free workplace programs. For more resources, visit SAMHSA's workplace page.

Government Efforts with Drug Problems in Palos Park, IL

The government of Palos Park, IL, and Cook County is actively working to combat drug abuse. Efforts include the Cook County Health Department partnering with local organizations to increase access to treatment and support. For more information, visit the Cook County Health Department.

State-level initiatives, such as the Illinois Opioid Action Plan, aim to reduce opioid-related deaths. Resources are provided for prevention and treatment programs across the state, offering critical support for communities like Palos Park, IL. Details are available at the Illinois Department of Human Services.

Local Drug Busts & News in Palos Park, IL

Palos Park, IL has witnessed several notable drug busts, helping curb illegal drug distribution in Cook County. In recent operations, local law enforcement, in collaboration with state agencies, seized significant quantities of narcotics. These efforts are crucial in maintaining community safety.

Events like the annual Drug Take Back Day, coordinated with the DEA, encourage residents of Palos Park to dispose of unused medications responsibly. These initiatives aim to prevent pharmaceutical pollution and accidental poisoning.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Palos Park, IL. Trusted by employers nationwide for accurate results and exceptional service.

Illinois DOT/Non DOT Physicals

Illinois Vision Tests

Illinois Audiograms

Illinois Respirator Fit Tests

Illinois Lift Tests

Illinois Background Checks

Clinical Testing Services

TB Testing in IL

Diabetes Testing in IL

Infectious Disease Testing in IL

Sickle Cell Anemia Testing in IL

Women/Men's Health Testing in IL

Resources & Citations

Cook County Public Health

Illinois Department of Human Services

SAMHSA

Illinois Department of Public Health

Drug Free Lake County

Department of Homeland Security

DEA

IBID

Illinois Meth Network

OSHA

Drug Testing Near Palos Park, IL

Goodings Grove, IL

Orland Hills, IL

Justice, IL

Willow Springs, IL

Stickney, IL

Crestwood, IL

Oak Lawn, IL

Alsip, IL

Hazel Green, IL

Hickory Hills, IL

Orland Park, IL

Worth, IL

Palos Hills, IL

Palos Heights, IL

Frequently Asked Questions

Customer Reviews